Novo Nordisk A/S (NVO)

40.52 -0.41 (-1.00%) USD  |  NYSE  |  Apr 17, 16:00
40.64 +0.12 (+0.30%) Pre-Market: 20:00
More

Novo Nordisk Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Evaxion AS Upgrade
Ascendis Pharma A/S Upgrade
Viking Therapeutics, Inc. --
DBV Technologies SA --
Cellectis SA Upgrade